nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—chronic obstructive pulmonary disease	0.289	1	CbGaD
Enzalutamide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0449	0.0875	CbGbCtD
Enzalutamide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0449	0.0875	CbGbCtD
Enzalutamide—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0406	0.0791	CbGbCtD
Enzalutamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0373	0.0728	CbGbCtD
Enzalutamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0373	0.0728	CbGbCtD
Enzalutamide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0341	0.0666	CbGbCtD
Enzalutamide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0341	0.0666	CbGbCtD
Enzalutamide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0304	0.0593	CbGbCtD
Enzalutamide—ALB—Prednisone—chronic obstructive pulmonary disease	0.0291	0.0567	CbGbCtD
Enzalutamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0286	0.0558	CbGbCtD
Enzalutamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0283	0.0552	CbGbCtD
Enzalutamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0193	0.0377	CbGbCtD
Enzalutamide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0189	0.0368	CbGbCtD
Enzalutamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0185	0.036	CbGbCtD
Enzalutamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0164	0.0321	CbGbCtD
Enzalutamide—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0161	0.0314	CbGbCtD
Enzalutamide—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0152	0.0297	CbGbCtD
Enzalutamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00965	0.0188	CbGbCtD
Enzalutamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00911	0.0178	CbGbCtD
Enzalutamide—Hallucination, visual—Montelukast—chronic obstructive pulmonary disease	0.00453	0.032	CcSEcCtD
Enzalutamide—Lower respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00354	0.025	CcSEcCtD
Enzalutamide—Lower respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00354	0.025	CcSEcCtD
Enzalutamide—Laryngitis—Tiotropium—chronic obstructive pulmonary disease	0.00208	0.0147	CcSEcCtD
Enzalutamide—Laryngitis—Montelukast—chronic obstructive pulmonary disease	0.00164	0.0116	CcSEcCtD
Enzalutamide—Laryngitis—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.0112	CcSEcCtD
Enzalutamide—Memory impairment—Montelukast—chronic obstructive pulmonary disease	0.00151	0.0106	CcSEcCtD
Enzalutamide—Disturbance in attention—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00965	CcSEcCtD
Enzalutamide—Musculoskeletal stiffness—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00951	CcSEcCtD
Enzalutamide—Musculoskeletal stiffness—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00951	CcSEcCtD
Enzalutamide—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00946	CcSEcCtD
Enzalutamide—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.0094	CcSEcCtD
Enzalutamide—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.0094	CcSEcCtD
Enzalutamide—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00882	CcSEcCtD
Enzalutamide—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00846	CcSEcCtD
Enzalutamide—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00829	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00815	CcSEcCtD
Enzalutamide—Cognitive disorder—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00776	CcSEcCtD
Enzalutamide—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.0074	CcSEcCtD
Enzalutamide—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00711	CcSEcCtD
Enzalutamide—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.000996	0.00703	CcSEcCtD
Enzalutamide—Injury—Arformoterol—chronic obstructive pulmonary disease	0.000954	0.00674	CcSEcCtD
Enzalutamide—Injury—Formoterol—chronic obstructive pulmonary disease	0.000954	0.00674	CcSEcCtD
Enzalutamide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000935	0.0066	CcSEcCtD
Enzalutamide—Injury—Montelukast—chronic obstructive pulmonary disease	0.000935	0.0066	CcSEcCtD
Enzalutamide—Injury—Salbutamol—chronic obstructive pulmonary disease	0.000901	0.00636	CcSEcCtD
Enzalutamide—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000883	0.00623	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00088	0.00621	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000873	0.00616	CcSEcCtD
Enzalutamide—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00598	CcSEcCtD
Enzalutamide—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000844	0.00596	CcSEcCtD
Enzalutamide—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000833	0.00588	CcSEcCtD
Enzalutamide—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000825	0.00583	CcSEcCtD
Enzalutamide—Fracture—Prednisone—chronic obstructive pulmonary disease	0.000818	0.00578	CcSEcCtD
Enzalutamide—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.000818	0.00578	CcSEcCtD
Enzalutamide—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.000804	0.00568	CcSEcCtD
Enzalutamide—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.000804	0.00568	CcSEcCtD
Enzalutamide—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00079	0.00558	CcSEcCtD
Enzalutamide—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000786	0.00555	CcSEcCtD
Enzalutamide—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000784	0.00554	CcSEcCtD
Enzalutamide—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000784	0.00554	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000774	0.00546	CcSEcCtD
Enzalutamide—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000768	0.00542	CcSEcCtD
Enzalutamide—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000768	0.00542	CcSEcCtD
Enzalutamide—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.000754	0.00532	CcSEcCtD
Enzalutamide—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.000746	0.00527	CcSEcCtD
Enzalutamide—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000742	0.00524	CcSEcCtD
Enzalutamide—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000741	0.00523	CcSEcCtD
Enzalutamide—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00523	CcSEcCtD
Enzalutamide—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000739	0.00522	CcSEcCtD
Enzalutamide—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000737	0.0052	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000733	0.00518	CcSEcCtD
Enzalutamide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000732	0.00517	CcSEcCtD
Enzalutamide—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000729	0.00515	CcSEcCtD
Enzalutamide—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.000729	0.00515	CcSEcCtD
Enzalutamide—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000714	0.00504	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000704	0.00497	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000704	0.00497	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00487	CcSEcCtD
Enzalutamide—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000688	0.00486	CcSEcCtD
Enzalutamide—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000682	0.00482	CcSEcCtD
Enzalutamide—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000666	0.0047	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.0047	CcSEcCtD
Enzalutamide—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000662	0.00467	CcSEcCtD
Enzalutamide—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000662	0.00467	CcSEcCtD
Enzalutamide—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000659	0.00465	CcSEcCtD
Enzalutamide—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00455	CcSEcCtD
Enzalutamide—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00455	CcSEcCtD
Enzalutamide—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00448	CcSEcCtD
Enzalutamide—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00448	CcSEcCtD
Enzalutamide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000633	0.00447	CcSEcCtD
Enzalutamide—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000624	0.00441	CcSEcCtD
Enzalutamide—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000621	0.00439	CcSEcCtD
Enzalutamide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000609	0.0043	CcSEcCtD
Enzalutamide—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.0043	CcSEcCtD
Enzalutamide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000608	0.00429	CcSEcCtD
Enzalutamide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.00429	CcSEcCtD
Enzalutamide—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.000606	0.00428	CcSEcCtD
Enzalutamide—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.00425	CcSEcCtD
Enzalutamide—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000602	0.00425	CcSEcCtD
Enzalutamide—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00425	CcSEcCtD
Enzalutamide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000601	0.00425	CcSEcCtD
Enzalutamide—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000599	0.00423	CcSEcCtD
Enzalutamide—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.00423	CcSEcCtD
Enzalutamide—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00423	CcSEcCtD
Enzalutamide—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00422	CcSEcCtD
Enzalutamide—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00422	CcSEcCtD
Enzalutamide—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00421	CcSEcCtD
Enzalutamide—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00421	CcSEcCtD
Enzalutamide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000596	0.00421	CcSEcCtD
Enzalutamide—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000595	0.0042	CcSEcCtD
Enzalutamide—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000595	0.0042	CcSEcCtD
Enzalutamide—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000591	0.00418	CcSEcCtD
Enzalutamide—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00059	0.00416	CcSEcCtD
Enzalutamide—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000589	0.00416	CcSEcCtD
Enzalutamide—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000587	0.00414	CcSEcCtD
Enzalutamide—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000584	0.00412	CcSEcCtD
Enzalutamide—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00411	CcSEcCtD
Enzalutamide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000581	0.0041	CcSEcCtD
Enzalutamide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.00406	CcSEcCtD
Enzalutamide—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00057	0.00402	CcSEcCtD
Enzalutamide—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00401	CcSEcCtD
Enzalutamide—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00399	CcSEcCtD
Enzalutamide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000565	0.00399	CcSEcCtD
Enzalutamide—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00398	CcSEcCtD
Enzalutamide—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000563	0.00397	CcSEcCtD
Enzalutamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000562	0.00397	CcSEcCtD
Enzalutamide—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00397	CcSEcCtD
Enzalutamide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.00393	CcSEcCtD
Enzalutamide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00392	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000553	0.00391	CcSEcCtD
Enzalutamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000532	0.00376	CcSEcCtD
Enzalutamide—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000532	0.00375	CcSEcCtD
Enzalutamide—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000532	0.00375	CcSEcCtD
Enzalutamide—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000531	0.00375	CcSEcCtD
Enzalutamide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.0037	CcSEcCtD
Enzalutamide—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00368	CcSEcCtD
Enzalutamide—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.00367	CcSEcCtD
Enzalutamide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00366	CcSEcCtD
Enzalutamide—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.00365	CcSEcCtD
Enzalutamide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00362	CcSEcCtD
Enzalutamide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00361	CcSEcCtD
Enzalutamide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00361	CcSEcCtD
Enzalutamide—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000502	0.00354	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00344	CcSEcCtD
Enzalutamide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.00341	CcSEcCtD
Enzalutamide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00341	CcSEcCtD
Enzalutamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00048	0.00339	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00326	CcSEcCtD
Enzalutamide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000456	0.00322	CcSEcCtD
Enzalutamide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.00322	CcSEcCtD
Enzalutamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00318	CcSEcCtD
Enzalutamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00318	CcSEcCtD
Enzalutamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00316	CcSEcCtD
Enzalutamide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00316	CcSEcCtD
Enzalutamide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00316	CcSEcCtD
Enzalutamide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00316	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000447	0.00315	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000447	0.00315	CcSEcCtD
Enzalutamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00311	CcSEcCtD
Enzalutamide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000439	0.0031	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000437	0.00309	CcSEcCtD
Enzalutamide—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00307	CcSEcCtD
Enzalutamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00304	CcSEcCtD
Enzalutamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00302	CcSEcCtD
Enzalutamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00302	CcSEcCtD
Enzalutamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.003	CcSEcCtD
Enzalutamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00299	CcSEcCtD
Enzalutamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00298	CcSEcCtD
Enzalutamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00298	CcSEcCtD
Enzalutamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00296	CcSEcCtD
Enzalutamide—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000419	0.00296	CcSEcCtD
Enzalutamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00296	CcSEcCtD
Enzalutamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00296	CcSEcCtD
Enzalutamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00292	CcSEcCtD
Enzalutamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000413	0.00292	CcSEcCtD
Enzalutamide—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00291	CcSEcCtD
Enzalutamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00041	0.0029	CcSEcCtD
Enzalutamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00286	CcSEcCtD
Enzalutamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000401	0.00283	CcSEcCtD
Enzalutamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00282	CcSEcCtD
Enzalutamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00279	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00277	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00277	CcSEcCtD
Enzalutamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00275	CcSEcCtD
Enzalutamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00275	CcSEcCtD
Enzalutamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00274	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00272	CcSEcCtD
Enzalutamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000382	0.0027	CcSEcCtD
Enzalutamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00268	CcSEcCtD
Enzalutamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000378	0.00267	CcSEcCtD
Enzalutamide—Injury—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00265	CcSEcCtD
Enzalutamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000375	0.00264	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00263	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00263	CcSEcCtD
Enzalutamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00262	CcSEcCtD
Enzalutamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00262	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00262	CcSEcCtD
Enzalutamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.0026	CcSEcCtD
Enzalutamide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000367	0.00259	CcSEcCtD
Enzalutamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00258	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00257	CcSEcCtD
Enzalutamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00257	CcSEcCtD
Enzalutamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000355	0.00251	CcSEcCtD
Enzalutamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.00249	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00248	CcSEcCtD
Enzalutamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00248	CcSEcCtD
Enzalutamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.00236	CcSEcCtD
Enzalutamide—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00223	CcSEcCtD
Enzalutamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00218	CcSEcCtD
Enzalutamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00218	CcSEcCtD
Enzalutamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00215	CcSEcCtD
Enzalutamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00215	CcSEcCtD
Enzalutamide—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00215	CcSEcCtD
Enzalutamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00214	CcSEcCtD
Enzalutamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00211	CcSEcCtD
Enzalutamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00208	CcSEcCtD
Enzalutamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00208	CcSEcCtD
Enzalutamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00206	CcSEcCtD
Enzalutamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00204	CcSEcCtD
Enzalutamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00203	CcSEcCtD
Enzalutamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00201	CcSEcCtD
Enzalutamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00201	CcSEcCtD
Enzalutamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00197	CcSEcCtD
Enzalutamide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000279	0.00197	CcSEcCtD
Enzalutamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00197	CcSEcCtD
Enzalutamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00191	CcSEcCtD
Enzalutamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00191	CcSEcCtD
Enzalutamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.0019	CcSEcCtD
Enzalutamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00187	CcSEcCtD
Enzalutamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00181	CcSEcCtD
Enzalutamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.0018	CcSEcCtD
Enzalutamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00175	CcSEcCtD
Enzalutamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00174	CcSEcCtD
Enzalutamide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00166	CcSEcCtD
Enzalutamide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00153	CcSEcCtD
Enzalutamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00149	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00148	CcSEcCtD
Enzalutamide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00148	CcSEcCtD
Enzalutamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00132	CcSEcCtD
Enzalutamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00127	CcSEcCtD
Enzalutamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00127	CcSEcCtD
Enzalutamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00125	CcSEcCtD
Enzalutamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00125	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00124	CcSEcCtD
Enzalutamide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00119	CcSEcCtD
Enzalutamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00117	CcSEcCtD
Enzalutamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00116	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00109	CcSEcCtD
Enzalutamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00109	CcSEcCtD
Enzalutamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00108	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00108	CcSEcCtD
Enzalutamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00103	CcSEcCtD
Enzalutamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.00103	CcSEcCtD
Enzalutamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000859	CcSEcCtD
Enzalutamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000847	CcSEcCtD
Enzalutamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00082	CcSEcCtD
Enzalutamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000792	CcSEcCtD
Enzalutamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00075	CcSEcCtD
Enzalutamide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.93e-05	0.00123	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.87e-05	0.00122	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.84e-05	0.00121	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.78e-05	0.0012	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	6.72e-05	0.00119	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	6.68e-05	0.00119	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.67e-05	0.00118	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.58e-05	0.00117	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.57e-05	0.00117	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.53e-05	0.00116	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.53e-05	0.00116	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.52e-05	0.00116	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.48e-05	0.00115	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.43e-05	0.00114	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.39e-05	0.00113	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.38e-05	0.00113	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.32e-05	0.00112	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.29e-05	0.00112	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.27e-05	0.00111	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.24e-05	0.00111	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.11e-05	0.00108	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	5.96e-05	0.00106	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.95e-05	0.00106	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.00104	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.86e-05	0.00104	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.78e-05	0.00103	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.7e-05	0.00101	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.7e-05	0.00101	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.64e-05	0.001	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.64e-05	0.001	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.57e-05	0.000988	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	5.36e-05	0.000952	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.35e-05	0.000949	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.32e-05	0.000944	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.31e-05	0.000944	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.31e-05	0.000942	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.28e-05	0.000938	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.27e-05	0.000936	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.25e-05	0.000931	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.24e-05	0.000931	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.24e-05	0.000931	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.24e-05	0.00093	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.2e-05	0.000923	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.2e-05	0.000923	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.07e-05	0.0009	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.04e-05	0.000894	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.02e-05	0.000891	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.97e-05	0.000882	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.96e-05	0.000881	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.96e-05	0.00088	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.89e-05	0.000868	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.85e-05	0.000861	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.85e-05	0.000861	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.85e-05	0.00086	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.82e-05	0.000856	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.81e-05	0.000854	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.78e-05	0.000849	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.77e-05	0.000847	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.74e-05	0.000841	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.68e-05	0.00083	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.63e-05	0.000823	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.62e-05	0.00082	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.59e-05	0.000816	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.57e-05	0.000811	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.54e-05	0.000806	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.53e-05	0.000804	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.51e-05	0.000802	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.45e-05	0.000791	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.45e-05	0.00079	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.29e-05	0.000762	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.27e-05	0.000759	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.24e-05	0.000753	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.24e-05	0.000752	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.23e-05	0.00075	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.17e-05	0.00074	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.11e-05	0.00073	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.05e-05	0.00072	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.96e-05	0.000704	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.96e-05	0.000702	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.94e-05	0.000699	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.93e-05	0.000697	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.91e-05	0.000695	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.85e-05	0.000684	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.75e-05	0.000666	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.73e-05	0.000662	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.7e-05	0.000656	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.69e-05	0.000656	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.68e-05	0.000653	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.67e-05	0.000652	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.55e-05	0.000631	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.48e-05	0.000617	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.47e-05	0.000617	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.46e-05	0.000614	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.43e-05	0.000609	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.38e-05	0.0006	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.29e-05	0.000585	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.24e-05	0.000575	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.22e-05	0.000572	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.21e-05	0.00057	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.2e-05	0.000567	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.15e-05	0.00056	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.14e-05	0.000558	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.13e-05	0.000555	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.11e-05	0.000552	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.03e-05	0.000538	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.000534	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.99e-05	0.000531	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.99e-05	0.000531	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.98e-05	0.00053	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.97e-05	0.000527	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.97e-05	0.000527	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.93e-05	0.00052	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.91e-05	0.000517	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.89e-05	0.000513	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.72e-05	0.000483	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.7e-05	0.00048	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.68e-05	0.000477	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.66e-05	0.000473	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.63e-05	0.000468	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.62e-05	0.000465	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.61e-05	0.000464	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.55e-05	0.000453	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.47e-05	0.000438	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.45e-05	0.000435	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.44e-05	0.000433	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.43e-05	0.000431	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.43e-05	0.000431	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.4e-05	0.000427	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.38e-05	0.000423	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.37e-05	0.000421	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.32e-05	0.000412	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.23e-05	0.000397	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.21e-05	0.000393	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.17e-05	0.000385	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.15e-05	0.000383	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.15e-05	0.000382	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.12e-05	0.000377	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.12e-05	0.000376	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.08e-05	0.00037	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.000361	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.97e-05	0.000351	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.94e-05	0.000345	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.93e-05	0.000343	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.91e-05	0.00034	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.91e-05	0.000338	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.89e-05	0.000335	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.87e-05	0.000331	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.85e-05	0.000328	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.82e-05	0.000324	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.82e-05	0.000322	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.81e-05	0.000321	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.000313	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000302	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.000296	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000287	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.61e-05	0.000286	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.6e-05	0.000284	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.000284	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.59e-05	0.000282	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000281	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.57e-05	0.000279	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.57e-05	0.000279	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.57e-05	0.000279	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.54e-05	0.000273	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.000272	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.47e-05	0.000262	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.46e-05	0.000259	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000256	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.43e-05	0.000255	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.43e-05	0.000253	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	0.00025	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.39e-05	0.000247	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000244	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000236	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.32e-05	0.000235	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000233	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.31e-05	0.000233	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000232	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.3e-05	0.000231	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.3e-05	0.00023	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.000229	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.29e-05	0.000229	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.29e-05	0.000228	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.000227	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.000224	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.000223	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.22e-05	0.000217	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000214	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.2e-05	0.000213	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.19e-05	0.000211	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.00021	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.000209	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.17e-05	0.000208	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000205	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000202	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000198	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.11e-05	0.000197	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000197	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.1e-05	0.000196	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000194	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	0.000194	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000193	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000192	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000181	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.02e-05	0.000181	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.01e-05	0.00018	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.89e-06	0.000176	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.75e-06	0.000173	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.65e-06	0.000171	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.65e-06	0.000171	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.6e-06	0.00017	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.52e-06	0.000169	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.1e-06	0.000162	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.09e-06	0.000161	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.02e-06	0.00016	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.97e-06	0.000159	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.89e-06	0.000158	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.87e-06	0.000157	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.62e-06	0.000153	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.58e-06	0.000152	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.48e-06	0.000151	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.41e-06	0.000149	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.38e-06	0.000149	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.36e-06	0.000148	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.29e-06	0.000147	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.92e-06	0.000141	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.86e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	7.75e-06	0.000138	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.74e-06	0.000137	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.57e-06	0.000134	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.41e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.25e-06	0.000129	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.13e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.56e-06	0.000116	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.28e-06	0.000111	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.24e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.95e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.87e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.86e-06	0.000104	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.72e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.6e-06	9.95e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.47e-06	9.71e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.47e-06	9.7e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.39e-06	9.56e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.34e-06	9.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.18e-06	9.2e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.15e-06	9.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.11e-06	9.07e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.52e-06	6.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.37e-06	5.98e-05	CbGpPWpGaD
